Fecal Occult Blood Test (FOBT) Market Report 2026

Fecal Occult Blood Test (FOBT) Market Overview

• Fecal Occult Blood Test (FOBT) market size has reached to $1.85 billion in 2025 • Expected to grow to $2.67 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: The Increasing Prevalence Of Colorectal Cancer Is Fueling The Market Growth Due To Rising Demand For Early Detection Methods • Market Trend: Innovation Driving The Shift Toward At-Home Diagnostic Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Fecal Occult Blood Test (FOBT) Market?

A fecal occult blood test (FOBT) is a diagnostic procedure that detects hidden blood in stool, which may indicate bleeding in the digestive tract. It is commonly used to screen for colorectal cancer and other gastrointestinal disorders. The test involves analyzing a small stool sample for traces of blood that are not visible to the naked eye. The main product types of fecal occult blood test include guaiac-based fecal occult blood test, immunochemical fecal occult blood test, and other product types. Guaiac-based fecal occult blood test refers to a diagnostic method that detects hidden blood in stool samples using a chemical reaction. The sample types include stool-based and other sample types. The various applications involved are Colorectal Cancer Screening, gastrointestinal bleeding, and other applications, and they are used by several end users such as hospitals, diagnostic laboratories, clinics, home care settings, and other end users.

What Is The Fecal Occult Blood Test (FOBT) Market Growth Forecast?

The fecal occult blood test (FOBT) market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic methods, growing adoption of at-home testing solutions, rising healthcare expenditure in emerging markets, expansion of personalized medicine approaches, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of immunochemical fobt kits, rising preference for home-based screening tests, growing focus on early colorectal cancer detection, expansion of point-of-care fobt devices, increasing development of high-sensitivity test reagents.

Global Fecal Occult Blood Test (FOBT) Market Segmentation

1) By Product Type: Guaiac-Based Fecal Occult Blood Test, Immunochemical Fecal Occult Blood Test, Other Product Types 2) By Sample Type: Stool-Based, Other Sample Types 3) By Application: Colorectal Cancer Screening, Gastrointestinal Bleeding, Other Applications 4) By End User: Hospitals, Diagnostic Laboratories, Clinics, Home Care Settings, Other End Users Subsegments: 1) By Guaiac-Based Fecal Occult Blood Test: Manual Guaiac Test Kits, Automated Guaiac Test Systems, Point-Of-Care Guaiac Test Devices, High Sensitivity Guaiac Reagents 2) By Immunochemical Fecal Occult Blood Test: Qualitative Immunochemical Test Kits, Quantitative Immunochemical Test Systems, Point-Of-Care Immunochemical Devices, High Sensitivity Immunochemical Reagents 3) By Other Product Types: Deoxyribonucleic Acid-Based Fecal Occult Blood Test Kits, Enzyme Immunoassay Test Kits, Chromatographic Fecal Occult Blood Test Devices, Combination Fecal Occult Blood Test Systems

What Is The Driver Of The Fecal Occult Blood Test (FOBT) Market?

The increasing prevalence and public health burden of colorectal cancer are expected to propel the growth of the fecal occult blood test (FOBT) market going forward. Colorectal cancer is a type of cancer that begins in the colon or rectum and often develops from abnormal growths known as polyps. Its prevalence is rising due to factors such as sedentary lifestyles, aging populations, and dietary habits, which increase the risk of cancer development in the digestive tract. The fecal occult blood test (FOBT) supports colorectal cancer screening efforts by detecting hidden blood in stool at an early stage, enabling timely diagnosis, improving treatment outcomes, and reducing disease progression. For instance, in February 2025, according to the Office for National Statistics (ONS), a UK-based government department, around 15,552 deaths due to colorectal cancer were registered in England and Wales in 2023, with provisional figures for 2024 indicating a similar level, highlighting the significant disease burden and the growing need for early screening and preventive diagnostic tools. Therefore, increasing prevalence of colorectal cancer is driving the growth of the fecal occult blood test (FOBT) industry.

Key Players In The Global Fecal Occult Blood Test (FOBT) Market

Major companies operating in the fecal occult blood test (fobt) market are F. Hoffmann-La Roche AG, Siemens Healthineers AG, Medline Industries Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Quidel Corporation, Randox Laboratories Ltd., BIOMERICA Inc., Aidian Oy, Meridian Bioscience Inc., CTK Biotech Inc., Eiken Chemical Co. Ltd., Hemosure Inc., Alfa Scientific Designs Inc., AdvaCare Pharma Inc., Biohit Oyj, Immunostics Inc., Apacor Ltd., Humasis Co. Ltd., Firstep Bioresearch Inc., Biopanda Reagents Ltd, Ameritek Inc.

Global Fecal Occult Blood Test (FOBT) Market Trends and Insights

Major companies operating in the fecal occult blood test (FOBT) market are focusing on developing innovative products such as at-home over-the-counter (OTC) FOBT kits to increase early detection rates and improve patient convenience. At-home over-the-counter (OTC) FOBT kits are non-invasive test kits that allow individuals to collect stool samples at home for detecting hidden blood, helping by providing early colorectal cancer screening and greater convenience compared to lab-based tests. For instance, in December 2023, DiaCarta Inc., a US-based precision diagnostic company, launched the iColon Fecal Occult Blood Test, an OTC at-home test that enables early detection of blood in stool, clinically relevant for gastrointestinal disorders and colorectal cancer. The iColon test is designed to be user-friendly and non-invasive, allowing patients to collect samples without medical supervision. It combines sensitive detection methods that improve accuracy over traditional guaiac-based FOBTs, reducing false negatives and enabling earlier intervention. Additionally, it supports timely follow-up with healthcare providers if abnormal results are detected, promoting proactive colorectal health management.

What Are Latest Mergers And Acquisitions In The Fecal Occult Blood Test (FOBT) Market?

In January 2023, SD Biosensor Inc., a South Korea–based healthcare technology company, and SJL Partners LLC, a South Korea–based private equity investment firm, acquired Meridian Bioscience Inc. for $1.53 billion. With this acquisition, the buyers aimed to expand their global diagnostics footprint, enhance product diversification, and strengthen technological and distribution capabilities in the in vitro diagnostics market, particularly in North America and other key regions. Meridian Bioscience Inc. is a US based life sciences and diagnostics company that specializes in developing fecal occult blood test (FOBT).

Regional Insights

North America was the largest region in the fecal occult blood test (FOBT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Fecal Occult Blood Test (FOBT) Market?

The fecal occult blood test (FOBT) market consists of sales of take-home guaiac kits, lateral-flow immunochemical strips, rapid one-step immunoassay cassettes, flushable reagent pads, stool collection devices, molecular stool tests, and multi-marker combination panels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Fecal Occult Blood Test (FOBT) Market Report 2026?

The fecal occult blood test (fobt) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fecal occult blood test (fobt) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.